{
    "pubmed_id": 33571162,
    "study_identifier": "PMID33571162_study-01",
    "study_name": "Durable SARS-CoV-2 B cell immunity after mild or severe disease",
    "publication_title": "Durable SARS-CoV-2 B cell immunity after mild or severe disease",
    "study_objective": "Most SARS-CoV-2-infected individuals develop S-RBD\u2013specific, class-switched rMBCs that resemble germinal center\u2013derived B cells induced by effective vaccination against other pathogens, providing evidence for durable B cell\u2013mediated immunity against SARS-CoV-2 after mild or severe disease.",
    "study_description": "Most SARS-CoV-2-infected individuals develop S-RBD\u2013specific, class-switched rMBCs that resemble germinal center\u2013derived B cells induced by effective vaccination against other pathogens, providing evidence for durable B cell\u2013mediated immunity against SARS-CoV-2 after mild or severe disease.",
    "primary_institution_name": "Johns Hopkins University",
    "study_personnel": [
        {
            "personnel_id": "PMID33571162_personnel-01",
            "honorific": "",
            "last_name": "Sabra",
            "first_name": "Klein",
            "suffixes": "",
            "organization": "Johns Hopkins University",
            "orchid_id": "",
            "email": "sklein2@jhu.edu",
            "seronet_title_in_study": "SeroNet Principal Investigator",
            "role_in_study": "Investigator",
            "site_name": "Johns Hopkins University"
        },
        {
            "personnel_id": "PMID33571162_personnel-02",
            "honorific": "",
            "last_name": "Cox",
            "first_name": "Andrea",
            "suffixes": "",
            "organization": "Johns Hopkins University",
            "orchid_id": "",
            "email": "acox@jhmi.edu",
            "seronet_title_in_study": "SeroNet Co-Principal Investigator",
            "role_in_study": "Investigator",
            "site_name": "Johns Hopkins University"
        },
        {
            "personnel_id": "PMID33571162_personnel-03",
            "honorific": "",
            "last_name": "Bailey",
            "first_name": "Justin",
            "suffixes": "",
            "organization": "Johns Hopkins University",
            "orchid_id": "",
            "email": "jbailey7@jhu.edu",
            "seronet_title_in_study": "Corresponding Author",
            "role_in_study": "Corresponding Author",
            "site_name": "Johns Hopkins University"
        }
    ],
    "study_file": [
        {
            "study_file_name": "jci-131-145516-s138.pdf",
            "study_file_description": "Supplemetary Data",
            "study_file_type": "Subject Data"
        },
        {
            "study_file_name": "PMID33571162_v1.2.5_reviewed.xlsm",
            "study_file_description": "Completed curation of the study into SeroNet Registry Template which includes SeroNet Study Descriptors.",
            "study_file_type": "Study Summary Description"
        }
    ],
    "study_link": [],
    "research_focus": "Immune Response",
    "study_type": "",
    "keyword": [
        "Adult",
        "Aged",
        "Antibodies",
        "Neutralizing blood",
        "B-Lymphocytes immunology",
        "Binding Sites immunology",
        "COVID-19 immunology",
        "virology",
        "Case-Control Studies",
        "Cohort Studies",
        "Female",
        "Humans",
        "Immunity Cellular",
        "Immunoglobulin Class Switching",
        "Immunologic Memory",
        "Male",
        "Middle Aged",
        "Pandemics",
        "SARS-CoV-2 immunology",
        "Severity of Illness Index",
        "Spike Glycoprotein",
        "Coronavirus chemistry",
        "Time Factors"
    ],
    "clinical_study_design": "Prospective Cohort",
    "in_silico_model_type": "",
    "protocol": {
        "protocol_id": "PMID33571162_protocol-01",
        "protocol_file_name": "PMID33571162_protocol-01.txt",
        "protocol_name": "PMID33571162_protocol-01",
        "protocol_description": "Study Protocol",
        "protocol_type": "Study Protocol"
    },
    "reported_health_condition": [
        "COVID-19"
    ],
    "sars_cov_2_vaccine_type": [],
    "clinical_outcome_measure": "SARS-CoV-2 B cell immunity",
    "enrollment_start_date": "",
    "enrollment_end_date": "",
    "number_of_study_subjects": 21,
    "age_unit": "Years",
    "minimum_age": 32,
    "maximum_age": 76,
    "study_human_cohort": [
        {
            "arm_id": "PMID33571162_aoc-01",
            "arm_name": "Covid-19 patients selected from Ambulatory cohort",
            "study_population_description": "7 patients with mild covid-19",
            "arm_type": "Observational",
            "ethnicity": [
                "Hispanic or Latino",
                "Not Hispanic or Latino"
            ],
            "race": [
                "Other"
            ],
            "race_specify": [
                "White",
                "Native Hawaiian or Other Pacific Islander",
                "Black or African American",
                "American Indian or Alaska Native"
            ],
            "description": "",
            "sex_at_birth": [
                "Other"
            ],
            "age_event": "Not Specified",
            "subject_phenotype": "",
            "assessment_name": [],
            "study_location": [
                "MD"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [
                "Post-acute sequelae of COVID-19 (>= 4 weeks)"
            ],
            "assessment_clinical_and_demographic_data_provenance": [],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Infected"
            ],
            "sars_cov_2_vaccine_type": [],
            "covid_19_disease_severity": [
                "Mild"
            ],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID33571162_aoc-02",
            "arm_name": "Covid-19 patients selected from hospitalized cohort",
            "study_population_description": "7 patients with moderate to severe covid-19",
            "arm_type": "Observational",
            "ethnicity": [
                "Not Hispanic or Latino"
            ],
            "race": [
                "Other"
            ],
            "race_specify": [
                "Black or African American I White I Other"
            ],
            "description": "",
            "sex_at_birth": [
                "Other"
            ],
            "age_event": "Not Specified",
            "subject_phenotype": "",
            "assessment_name": [],
            "study_location": [
                "MD"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [
                "Post-acute sequelae of COVID-19 (>= 4 weeks)"
            ],
            "assessment_clinical_and_demographic_data_provenance": [],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Infected"
            ],
            "sars_cov_2_vaccine_type": [],
            "covid_19_disease_severity": [
                "Moderate I Severe"
            ],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID33571162_aoc-03",
            "arm_name": "Healthy controls",
            "study_population_description": "7 healthy controls",
            "arm_type": "Observational",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Other"
            ],
            "age_event": "Not Specified",
            "subject_phenotype": "",
            "assessment_name": [],
            "study_location": [
                "MD"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [],
            "assessment_clinical_and_demographic_data_provenance": [],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Uninfected"
            ],
            "sars_cov_2_vaccine_type": [],
            "covid_19_disease_severity": [],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        }
    ],
    "study_model_cohort": [],
    "planned_visit": [
        {
            "visit_id": "PMID33571162_pv-01",
            "visit_name": "Median time since symptom onset in days measured in ambulatory patients 61( 45\u201368)",
            "visit_order_number": 1,
            "visit_min_start_day": 45,
            "visit_max_start_day": 68,
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID33571162_pv-02",
            "visit_name": "Median time since symptom onset in days measured in hospitalized patients 46 (39\u2013104)",
            "visit_order_number": 2,
            "visit_min_start_day": 39,
            "visit_max_start_day": 104,
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID33571162_assessment_recorded_pv",
            "visit_name": "Visit where an assessment is recorded",
            "visit_order_number": 3,
            "visit_min_start_day": 0,
            "visit_max_start_day": "",
            "visit_start_rule": ""
        }
    ],
    "experiment": [
        {
            "arm_id": [
                "PMID33571162_aoc-01 | PMID33571162_aoc-02"
            ],
            "associated_first_planned_visit_id": [
                "PMID33571162_pv-01 | PMID33571162_pv-02"
            ],
            "assay_type": "Flow Cytometry",
            "experiment_name": "Flow Cytometry",
            "experiment_results_file_name": "na",
            "biospecimen_type": [
                "Peripheral Blood Mononuclear Cell (PBMC)"
            ],
            "biospecimen_collection_point": [
                "Post-symptom onset"
            ],
            "sars_cov_2_antigen": [
                "Receptor Binding Domain (RBD)"
            ],
            "assay_use": "",
            "manufacture": "components from multiple manufacturers",
            "catalog_number": "",
            "virus_target": [
                "SARS CoV-2"
            ],
            "antibody_isotype": [
                "IgG"
            ],
            "reporting_units": "",
            "assay_reporting_format": "Quantitative"
        },
        {
            "arm_id": [
                "PMID33571162_aoc-01 | PMID33571162_aoc-02"
            ],
            "associated_first_planned_visit_id": [
                "PMID33571162_pv-01 | PMID33571162_pv-02"
            ],
            "assay_type": "Neutralizing Antibody Titer Assay",
            "experiment_name": "Neutralizing Antibody Titer Assay",
            "experiment_results_file_name": "na",
            "biospecimen_type": [
                "Plasma"
            ],
            "biospecimen_collection_point": [
                "Post-symptom onset"
            ],
            "sars_cov_2_antigen": [
                "Full Length Spike Trimer"
            ],
            "assay_use": "",
            "manufacture": "components from multiple manufacturers",
            "catalog_number": "",
            "virus_target": [
                "SARS CoV-2"
            ],
            "antibody_isotype": [
                "IgG"
            ],
            "reporting_units": "",
            "assay_reporting_format": "Quantitative"
        },
        {
            "arm_id": [
                "PMID33571162_aoc-01 | PMID33571162_aoc-02"
            ],
            "associated_first_planned_visit_id": [
                "PMID33571162_pv-01 | PMID33571162_pv-02"
            ],
            "assay_type": "ELISA",
            "experiment_name": "ELISA",
            "experiment_results_file_name": "na",
            "biospecimen_type": [
                "Plasma"
            ],
            "biospecimen_collection_point": [
                "Post-symptom onset"
            ],
            "sars_cov_2_antigen": [
                "Full Length Spike Trimer"
            ],
            "assay_use": "",
            "manufacture": "components from multiple manufacturers",
            "catalog_number": "",
            "virus_target": [
                "SARS CoV-2"
            ],
            "antibody_isotype": [
                "IgG"
            ],
            "reporting_units": "",
            "assay_reporting_format": "Quantitative"
        }
    ],
    "geriatric_subjects": "No",
    "pediatric_subjects": "No",
    "pregnant_subjects": "Not Specified",
    "sars_cov_2_antibodies_measured": "Yes",
    "survey_instrument_shared": "Not Specified",
    "who_disease_severity_scale_used": "Not Specified",
    "inclusion_exclusion": [
        {
            "inclusion_exculusion_id": "PMID33571162_ie_01",
            "inclusion_criterion": "SARS-CoV-2 Antibodies Measured",
            "inclusion_criterion_category": "inclusion"
        },
        {
            "inclusion_exculusion_id": "PMID33571162_ie_02",
            "inclusion_criterion": "Geriatric subjects",
            "inclusion_criterion_category": "Inclusion"
        },
        {
            "inclusion_exculusion_id": "PMID33571162_ie_03",
            "inclusion_criterion": "Pediatric subjects",
            "inclusion_criterion_category": "exclusion"
        }
    ]
}
